Hotspots and frontiers in pulmonary arterial hypertension research: a bibliometric and visualization analysis from 2011 to 2020

Bioengineered. 2022 Jun;13(6):14667-14680. doi: 10.1080/21655979.2022.2100064.

Abstract

Pulmonary arterial hypertension (PAH) is a group of devastating and progressive disorders, resulting in relentless increases in pulmonary vascular resistance. The number of studies related to PAH has been increasing in recent years. Our study aims to illustrate trends in PAH research over the past decade using bibliometric analysis. Science Citation Index-Expanded was adopted to search studies concerning PAH between 2011 and 2020. The bibliographic information was converted and analyzed automatically using a bibliometric package in R software and citespace. The annual quantity of publications on PAH showed an overall increase last decade. The United States was the most prolific country with 2,479 publications, and it was also the country that cooperated most with other countries. Hôpital Bicêtre made important research achievements on PAH and was a leader in study cooperation. Marc Humbert led the PAH field by publishing 150 articles in the past decade. During the past decade, there was a close transnational relation among countries or regions, institutions and authors. Further, Circulation was the most cited journal, followed by the Journal of the American College of Cardiology and the American Journal of Respiratory and Critical Care Medicine, with 3,895, 3,406, and 3,170 citations, respectively. The global research status and trend of PAH are deeply understood for the first time using bibliometric and visual methods, and the results of our study bring us a valuable reference for clinical researchers.

Keywords: Pulmonary arterial hypertension; bibliometric analysis; selexipag; treprostinil; visualization.

Plain language summary

This is the first study to illustrate trends in pulmonary arterial hypertension research using bibliometric analysis.Our study provides extensive and in-depth directions for researchers.Our study may benefit further researches on the etiology, diagnosis, and treatment of pulmonary arterial hypertension.

Publication types

  • Review

MeSH terms

  • Bibliometrics
  • Humans
  • Pulmonary Arterial Hypertension*
  • United States

Grants and funding

The work was supported by the National Natural Science Foundation of China (No. 81873523, and No. 82070490) to HZ and Hubei provincial Engineering Research Center.